Haploidentical Transplant for MDS | Aplastic Anemia & MDS International Foundation Return to top.

Haploidentical Transplant for MDS

Registration for this Webinar is now open. Please use the form below to register and receive a link to watch live on May 18, 2021.

Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Presentation Date: 
Tue, 05/18/2021 - 1:00pm (EDT)

Dr. Shaffer will provide an overview of the haploidentical transplant process and discuss how this treatment option might be right for some MDS patients. 

Participants will be able to submit their questions during the session via the Q & A window and we will do our best to get to all live questions.  To submit a question in advance, please send an email to help@aamds.org

Dr. Brian Shaffer is a board certified hematologist specializing in bone marrow transplantation for leukemia, myelodysplastic syndromes (MDS), lymphoma and other bone marrow disorders.  He works with a team at Memorial Sloane Kettering Cancer Center to provide comprehensive cancer care to patients.  

Dr. Shaffer is a researcher as well as a clinician who focuses on the role of Natural Killer (NK) cells in outcomes after transplant.  NK cells are white blood cells that have anti-tumor and anti-infection properties.  Dr. Shaffer is also focused on improving outcomes for transplant patients without a matched sibling donor through his work as a principal investigator for a number of ongoing clinical trials. 

Share with addtoany.com.